Fields, K. K., Elfenbein, G. J., Saleh, R. A., Zorsky, P. E., Janssen, W. E., Perkins, J. B., … Lyman, G. H. (1992). Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: Focus on breast cancer and lymphoma. Hematological Oncology, 10(1), 61–74.

Fields, K. K., G. J. Elfenbein, R. A. Saleh, P. E. Zorsky, W. E. Janssen, J. B. Perkins, T. G. Saleh, et al. “Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: Focus on breast cancer and lymphoma.” Hematological Oncology 10, no. 1 (1992): 61–74.

Fields KK, Elfenbein GJ, Saleh RA, Zorsky PE, Janssen WE, Perkins JB, et al. Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: Focus on breast cancer and lymphoma. Hematological Oncology. 1992;10(1):61–74.

Fields, K. K., et al. “Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: Focus on breast cancer and lymphoma.” Hematological Oncology, vol. 10, no. 1, 1992, pp. 61–74.

Fields KK, Elfenbein GJ, Saleh RA, Zorsky PE, Janssen WE, Perkins JB, Saleh TG, Piazza JT, Kronish LE, Machak MC, Lyman GH. Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: Focus on breast cancer and lymphoma. Hematological Oncology. 1992;10(1):61–74.